Alnylam Pharmaceuticals Inc (ALNY)
245.50
+6.63
(+2.78%)
USD |
NASDAQ |
Dec 20, 16:00
245.46
-0.04
(-0.02%)
After-Hours: 20:00
Alnylam Pharmaceuticals Market Cap: 31.66B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Pfizer Inc | 149.38B |
BridgeBio Pharma Inc | 5.007B |
Gilead Sciences Inc | 115.37B |
Regeneron Pharmaceuticals Inc | 77.13B |
Sarepta Therapeutics Inc | 11.36B |
Market Cap Related Metrics
PS Ratio | 14.86 |
Price to Book Value | 978.70 |
Price to Free Cash Flow | 1937.51 |
Price | 245.50 |
Earnings Yield | -1.07% |